A single-arm phase II trial of pazopanib in patients with advanced non-small cell lung cancer with non-squamous histology with disease progression on bevacizumab containing therapy Article

cited authors

  • Weiss, Jared M.; Villaruz, Liza C.; Socinski, Mark A.; Ivanova, Anastasia; Grilley-Olson, Juneko; Dhruva, Nirav; Stinchcombe, Thomas E.

authors

Publication Date

  • November 1, 2014

webpage

published in

category

keywords

  • Angiogenesis
  • Clinical trial
  • Multi-targeted tyrosine kinase inhibitors
  • Non-small cell lung cancer
  • Second-line therapy
  • Targeted therapy

start page

  • 288

end page

  • 290

volume

  • 86

issue

  • 2